| Dr Joseph W Terry, OD | |
|
3151 Leitchfield Rd, Owensboro, KY 42303-2115 | |
| (270) 689-1901 | |
| Not Available |
| Full Name | Dr Joseph W Terry |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 27 Years |
| Location | 3151 Leitchfield Rd, Owensboro, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275699027 | NPI | - | NPPES |
| 77013951 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1395DT (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dr Joe Terry And Associates, Inc | 5395821797 | 3 |
News Archive
Perrigo Company announced on May 26, 2010 that it had acquired rights to Novel Laboratories' pending ANDA for HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets).
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Just when you thought those one or two glasses of wine were of benefit to your health, a new study is now saying that is not necessarily the case.
London-based DeepMind which is owned by Google's parent company Alphabet, is coming up with Artificial Intelligence based devices that can help diagnose eye conditions accurately.
› Verified 1 days ago
| Provider Name | Dr Joe Terry And Associates, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1073798054 PECOS PAC ID: 5395821797 Enrollment ID: O20080326000244 |
News Archive
Perrigo Company announced on May 26, 2010 that it had acquired rights to Novel Laboratories' pending ANDA for HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets).
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Just when you thought those one or two glasses of wine were of benefit to your health, a new study is now saying that is not necessarily the case.
London-based DeepMind which is owned by Google's parent company Alphabet, is coming up with Artificial Intelligence based devices that can help diagnose eye conditions accurately.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph W Terry, OD 3151 Leitchfield Rd, Owensboro, KY 42303-2115 Ph: (270) 689-1901 | Dr Joseph W Terry, OD 3151 Leitchfield Rd, Owensboro, KY 42303-2115 Ph: (270) 689-1901 |
News Archive
Perrigo Company announced on May 26, 2010 that it had acquired rights to Novel Laboratories' pending ANDA for HalfLytely® and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets).
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
The commercial failure of Exubera- (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs? The science and circumstances behind the Lilly-Alkermes decision to discontinue trials of the AIR- inhaled insulin product are explored in a special supplement to Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The supplement is available free online at www.liebertpub.com/dia
Just when you thought those one or two glasses of wine were of benefit to your health, a new study is now saying that is not necessarily the case.
London-based DeepMind which is owned by Google's parent company Alphabet, is coming up with Artificial Intelligence based devices that can help diagnose eye conditions accurately.
› Verified 1 days ago
Dr. Kaitlin Breanne Nesty, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3310 Professional Park Ste 101, Owensboro, KY 42303 Phone: 270-683-2101 Fax: 270-683-2507 | |
Taylor Gaddis Brewer, Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1705 Frederica St, Owensboro, KY 42301 Phone: 270-683-2122 | |
Family First Vision Care Kentucky, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5035 Frederica St, Owensboro, KY 42301 Phone: 270-688-8811 | |
Haleigh Stringer, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2905 New Hartford Rd, Owensboro, KY 42303 Phone: 270-685-4966 Fax: 270-686-8058 | |
Dr Joe Terry And Associates, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 5040 Frederica St Ste A, Owensboro, KY 42301 Phone: 270-685-0247 Fax: 270-713-7932 | |
Elizabeth Mauzy Martin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 221 Allen St, Owensboro, KY 42303 Phone: 270-685-4966 Fax: 270-686-8058 | |
Jaki Richter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 411 Park Plaza Dr, Owensboro, KY 42301 Phone: 270-683-2020 |